Emikind-MD 10 Tablets

Babies: It is not applicable for babies. Lactating mother: It is unsafe to use during breastfeeding.
Limited studies have shown that the drug may pass into breast milk. Pregnancy: Information regarding the use of emikind tablets during pregnancy is not available. Seek doctor advice before using this medication Driving: Emikind tablets may affect your vision or make you feel sleepy and dizzy.
Do not drive if these symptoms occur. Alcohol: It is unsafe to consume alcohol with emikind tablets.
Seek doctor advice before using this medication Kidney: Emikind tablets should be used in caution with patients suffering from kidney disease. You may require a dose adjustment.
Seek doctor advice before using this medication. Liver: Emikind tablets should be used in caution with patients suffering from liver disease. You may require a dose adjustment.
Seek doctor advice before using this medication..

Drowsiness Orthostatic hypotension.

Emikind tablet dopamine antagonist. It works by blocking the action of dopamine, thus producing an anti-psychotic and anti-vomiting effect.
.

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Emikind tablet is a dopamine antagonist used to treat nausea, vomiting, migraine, and vertigo (dizziness) • It is also used to treat dizziness which is associated with inner ear problems such as meniere's syndrome • Emikind tablets may affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur • Avoid consuming alcohol with emikind tablets, as it may affect your vision or make you feel sleepy and dizzy.
Do not drive if these symptoms occur • Avoid heavy exercising and drink plenty of fluids. It makes you more likely to get heatstroke • Avoid exposure to sunlight while taking this medicine.
It can cause your skin to be more sensitive to sunlight.

Contraindicated • Emikind + Disopyramide: Concurrent use of both drugs leads to an increased qtc interval • Emikind + Ibutilide: Concurrent use of both drugs leads to an increased qtc interval • Emikind + Indapamide: Concurrent use of both drugs leads to an increased qtc interval Serious • Emikind + Aminolevulinic acid: Concurrent use of both drugs leads to an increase in the toxicity of aminolevulinic acid • Emikind + Amiodarone: Concurrent use of both drugs leads to an increased qtc interval Monitor closely • Emikind + Abobotulinumtoxina: Concurrent use of both drugs leads to increased effects of prochlorperazine by pharmacodynamic synergism • Emikind + Alprazolam: Concurrent use of both drugs leads to an increased sedation.